HUA XIA EYE HOSPITAL GROUP CO., LTD.
Announcement on Using Remaining Excess Raised Funds to Permanently Supplement Working Capital
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
HUA XIA EYE HOSPITAL GROUP CO., LTD. (hereinafter referred to as the "Company") held its second meeting of the fourth Board of Directors on April 24, 2026, and deliberated and passed the "Proposal on Using Remaining Excess Raised Funds to Permanently Supplement Working Capital." It was agreed that the Company would permanently supplement working capital with RMB 37.42151 million (balance as of March 31, 2026, including interest income; the actual amount shall be based on the balance of the special account on the day of fund transfer). This proposal needs to be submitted to the Company's general meeting of shareholders for deliberation. The details are as follows:
I. Basic Situation of Raised Funds
As approved by the China Securities Regulatory Commission's "Approval on the Registration of Initial Public Offering of Shares by HUA XIA EYE HOSPITAL GROUP CO., LTD." (Zhengjian Xuke [2022] No. 2085), the Company issued 60 million ordinary shares (A shares) at an issuance price of RMB 50.88 per share. The total amount of raised funds was RMB 3,052.80 million. After deducting issuance expenses of RMB 284.3075 million (excluding value-added tax), the net amount of raised funds was RMB 2,768.4925 million. These raised funds were received on October 28, 2022. Rongcheng Certified Public Accountants (Special General Partnership) audited the receipt of the raised funds and issued the "Capital Verification Report" (Rongcheng Yanzhi [2022] No. 361Z0068). The Company implemented a special account deposit system, and upon receipt, the raised funds were deposited into the special account for raised funds.
II. Basic Situation of Raised Fund Investment Projects
The initial public offering of shares and listing on the ChiNext Market Prospectus disclosed by the Company outlines the investment projects for the raised funds and the usage plan as follows:
| No. | Raised Fund Investment Project | Total Investment | Committed Raised Fund Investment Amount |
|---|---|---|---|
| 1 | Tianjin HUA XIA EYE HOSPITAL Project | 61,000,000.00 | 61,000,000.00 |
| 2 | Regional Optometry Center Construction Project | 229,638,100.00 | 229,638,100.00 |
| 3 | Upgrade of Existing Hospital Medical Service Capacity Project | 84,000,000.00 | 84,000,000.00 |
| 4 | Informationized Operation Management System Construction Project | 203,868,000.00 | 203,868,000.00 |
| No. | Raised Fund Investment Project | Total Investment | Committed Raised Fund Investment Amount |
|---|---|---|---|
| 5 | Supplement Working Capital Project | 200,000,000.00 | 200,000,000.00 |
| Total | 778,506,100.00 | 778,506,100.00 |
The net amount of funds actually raised from the Company's initial public offering of shares was RMB 2,768.4925 million. After deducting the demand for raised fund investment projects, the Company's excess raised funds amounted to RMB 1,989.9864 million.
III. Usage of Excess Raised Funds
- Regarding the permanent supplementation of working capital with part of the excess raised funds